Pathophysiology of airflow limitation in chronic obstructive pulmonary disease.
Hogg JC.
Lancet. 2004 Aug 21-27;364(9435):709-21. doi: 10.1016/S0140-6736(04)16900-6.
Alpha1-antitrypsin review.
Stockley RA.
Clin Chest Med. 2014 Mar;35(1):39-50. doi: 10.1016/j.ccm.2013.10.001. Epub 2013 Dec 12.
Panlobular emphysema is associated with COPD disease severity: A study of emphysema subtype by computed tomography.
Wilgus ML, Abtin F, Markovic D, Tashkin DP, Phillips JE, Buhr RG, Flynn MJ, Dembek M, Cooper CB, Barjaktarevic I.
Respir Med. 2022 Feb;192:106717. doi: 10.1016/j.rmed.2021.106717. Epub 2021 Dec 14.
[Panlobular emphysema].
Tanaka H, Yamagishi M.
Ryoikibetsu Shokogun Shirizu. 1994;(3):319-21.
[Panlobular emphysema].
Labrune S.
Rev Infirm. 1988 Feb;38(3):35-7.
Bullous emphysema.
Teramoto S, Fukuchi Y.
Curr Opin Pulm Med. 1996 Mar;2(2):90-6. doi: 10.1097/00063198-199603000-00003.
Centrilobular emphysema and panlobular emphysema: two different diseases.
Anderson AE Jr, Foraker AG.
Thorax. 1973 Sep;28(5):547-50. doi: 10.1136/thx.28.5.547.
[Pulmonary emphysema].
Busarova GA, Vorob'ev LP.
Ter Arkh. 1991;63(7):142-7.
Micro-Computed Tomography Comparison of Preterminal Bronchioles in Centrilobular and Panlobular Emphysema.
Tanabe N, Vasilescu DM, McDonough JE, Kinose D, Suzuki M, Cooper JD, Paré PD, Hogg JC.
Am J Respir Crit Care Med. 2017 Mar 1;195(5):630-638. doi: 10.1164/rccm.201602-0278OC.
SERPINE2 haplotype as a risk factor for panlobular type of emphysema.
Kukkonen MK, Tiili E, Hämäläinen S, Vehmas T, Oksa P, Piirilä P, Hirvonen A.
BMC Med Genet. 2011 Dec 7;12:157. doi: 10.1186/1471-2350-12-157.
